Introduction
Many clinical trials are conducted to compare a treatment group with a control group on several endpoints. Often, the treatment is expected to have a positive effect on all endpoints. Inappropriateness of Hotelling's T2 test for this problem has been noted by several authors (cf., Meier, 1975) . As an alternative to Hotelling's T2 test, O'Brien (1984) proposed his ordinary least squares (OLS) and generalized least squares (GLS) tests, which possess high power against the restricted alternative that the treatment has the same positive standardized effect on all endpoints. In the one-sample problem, for the more general alternative that the mean vector lies in the positive orthant, the exact likelihood ratio (LR) tests were derived by Kud6 (1963) assuming a known covariance matrix and by Perlman (1969) assuming an unknown covariance matrix. However, these test statistics are complicated, and their null distributions are difficult to obtain. For the Perlman test statistic, the null distribution is not free of the unknown covariance matrix. To obviate some of these difficulties, Tang, Gnecco, and Geller (1989) proposed an approximate likelihood ratio (ALR) test for the one-sample problem assuming a known covariance matrix. It provides an easyto-use approximation to Kud6's test. When extended to the two-sample problem, it has better power properties compared with O'Brien's (1984) OLS and GLS tests for most alternatives in the positive orthant. This article focuses on the ALR test.
In practical applications, the population covariance matrix is always unknown and the sample covariance matrix must be used to estimate it. This results in a highly liberal ALR test if one uses the null distribution derived by Tang et al., which assumes a known covariance matrix (see Reitmeir and Wassmer, 1996; Sankoh et al., 1999 The outline of the article is as follows. In Section 2, we set the notation and review the ALR test for the two-sample problem in the known common covariance matrix (homoscedastic) case. In Section 3, we propose the approximation to its small-sample null distribution in the unknown covariance matrix case. In Section 4, we extend the approximation to the unequal unknown covariance matrices (heteroscedastic) case. In Section 5, we present the results of simulations that demonstrate the accuracy of the proposed approximations. An example is given in Section 6. Finally, a discussion about some anomalies of the LR tests (including the ALR test) is given in Section 7.
Notation, Problem Formulation, and the ALR Test
Suppose that there are two independent treatment groups with ni and n2 subjects, on each of whom m > 2 endpoints are measured. Treatment 1 is the test treatment and treatment 2 is the control. Let Xijk denote the measurement on the kth endpoint for the jth subject in the ith treatment group. (Note that the vk are not marginally t-distributed for m > 1.) Also, as v -4 o0, both expressions approach 5m/4, which is the variance of the x2 distribution. For other cases, the variance of the F distribution is found to be higher, suggesting that the F approximation will be conservative. Critical constants for the F approximation are given in Table 1 Table 2 . The results for the E :$ I case were similar and hence are not reported to save space. In particular, the type I error probability of g(v) is always well controlled at or slightly below Ol = 0.05. In no case did it exceed the upper 95% rejection limit of 0.05 + 1.96{(0.05)(0.95)/10, 000}1/2 = 0.0543. From these simulation results, it appears that the null distribution of g(v) does not depend in a significant way on E. This observation is bolstered by the fact that the first two moments of g(v) (the second moment expression being approximate) given in Section 3 also do not depend on E. Finally, the results show that the x2 approximation is liberal in all cases. For fixed v, its liberalism increases as m increases.
Heteroscedastic Case
The type I error probability of the ALR test was simulated for nominal Ol = .05, m = 4 and 8, and ni = n2 = 20,30, and 50. For each choice of m and ni = n2, a total of eight combinations of (El, E2) matrices were examined. These were parameterized as follows: treatment group, (El)ii =1 (1 < i < m/2), (El)ii = uj2 (m/2 < i < m) and (El)ij = Pi(El)l/i2(El)jl/2
(1 < i =A j < m); control group, (E2)ii 2= = < i < m), (E2)ij = P2 (1 < i j< m).
All simulations were based on 10,000 runs. In each run, the P-value of the simulated g(w) statistic was computed using the F approximation. The proportion of runs for which the P-value < al gives an estimate of the type I error probability. The results are summarized in Table 3 .
From these results, we see that the type I error probability is well controlled for ni = n2 = 30 and 50, but for nl = n2 = 20, there are several cases (especially for m = 8) where the estimated type I error probability exceeds the 0.05-level significantly; these cases are marked with a superscript a. In this trial, it was of interest to determine if autotransfusion (donation of the patient's own blood) makes surgical patients more sensitive to postoperative risk of infection (pneumonia, wound infection, etc.). This conjecture was supported by the fact that erythrocytes could be activated in the extracorporal circuit. Thirty patients about to undergo bypass surgery were randomized into two groups of 15 patients each. The treatment group received autotransfusion by means of a Pfizer-Shirley system, while the control group did not receive autotransfusion. As a measure of the risk, interleukin-6 (which is a proinflammation interleukin) plasma concentration (in picogram/ml) levels were measured for each patient at the time of surgical cut (to) and on six successive occasions (to + 1, to + 3, to + 6, to + 12, to + 24, and to + 48 hours). Note that here we have repeated measures data on the same endpoint. This makes the assumption of one-sided effect more plausible than if we had different endpoints. The first two measurements were dropped because of some missing and some inconsistent data, and the natural logarithmic transformation was applied to the remaining five measurements. The resulting data are shown in Table 4 . The mean vectors and the sample covariance matrices for the two groups are as follows: Table 3 Simulation estimates of the type I error probability in the heteroscedastic case using the F approximation with estimated degrees of freedom (a = .05) The ALR test statistic equals g(v) = 14.60. Using the x2 approximation, the P-value is 0.0022, whereas using the F approximation, the P-value is 0.0145. Note the liberalism of the x2 approximation. The F-approximated P-value is in line with the P-value of 0.0199 obtained using the standardized sum statistic of Liiuter (1996) and 0.0104 obtained using the OLS statistic of O'Brien (1984). For comparison purposes, the heteroscedastic ALR test was also performed. Because ni = n2, E is the same in the heteroscedastic case as in the homoscedastic case. Therefore, The above-mentioned anomalies translate to the ALR test as well. Generally, they tend to occur when the endpoints are highly positively correlated. In this case, the endpoints with very dissimilar negative mean differences, when projected onto the positive orthant, can generate a large value of the LR statistic that warrants rejection.
It is not our intention to get into the pros and cons of tests for multiparameter hypothesis testing problems that seem to afflict LR as well as other tests. Suffice it to say that the above anomalies should not present a serious problem in most practical situations. When the correlation is high, it is unusual for the mean differences to be very dissimilar and the LR statistic to be large as a result. If a negative effect on some endpoint(s) cannot be ruled out a priori, then a onesided test should not be used. When a one-sided test is applicable, the ALR test is a good choice that performs better than the more popular OLS test. We have offered an accurate method for applying the ALR test in small samples. The proposed approximations are very simple to implement by using a C program available for download at http: //users. iems . northwestern. edu/-aj it.
